ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) return on equity

annual ROE:

38.89%+53.62%(+364.02%)
December 31, 2024

Summary

  • As of today (August 31, 2025), ACAD annual return on equity is 38.89%, with the most recent change of +53.62% (+364.02%) on December 31, 2024.
  • During the last 3 years, ACAD annual ROE has risen by +67.64% (+235.27%).
  • ACAD annual ROE is now -46.31% below its all-time high of 72.43%, reached on December 31, 2010.

Performance

ACAD ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADprofitability metrics

quarterly ROE:

32.53%-4.92%(-13.14%)
June 30, 2025

Summary

  • As of today (August 31, 2025), ACAD quarterly return on equity is 32.53%, with the most recent change of -4.92% (-13.14%) on June 30, 2025.
  • Over the past year, ACAD quarterly ROE has increased by +25.49% (+362.07%).
  • ACAD quarterly ROE is now -77.70% below its all-time high of 145.90%, reached on December 31, 2010.

Performance

ACAD quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ACAD ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+364.0%+362.1%
3 y3 years+235.3%+181.2%
5 y5 years+197.4%+188.9%

ACAD ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+184.8%-21.8%+167.7%
5 y5-yearat high+184.8%-21.8%+167.7%
alltimeall time-46.3%+128.0%-77.7%+111.8%

ACAD ROE History

DateAnnualQuarterly
Jun 2025
-
32.53%(-13.1%)
Mar 2025
-
37.45%(-10.0%)
Dec 2024
38.89%(-364.0%)
41.59%(+52.2%)
Sep 2024
-
27.32%(+288.1%)
Jun 2024
-
7.04%(-1776.2%)
Mar 2024
-
-0.42%(-97.3%)
Dec 2023
-14.73%(-67.9%)
-15.60%(-58.9%)
Sep 2023
-
-37.99%(+39.3%)
Jun 2023
-
-27.28%(-22.2%)
Mar 2023
-
-35.08%(-27.0%)
Dec 2022
-45.89%(+59.6%)
-48.07%(+6.8%)
Sep 2022
-
-45.03%(+12.4%)
Jun 2022
-
-40.08%(+0.9%)
Mar 2022
-
-39.73%(+36.4%)
Dec 2021
-28.75%(-32.3%)
-29.13%(-8.9%)
Sep 2021
-
-31.97%(-24.5%)
Jun 2021
-
-42.33%(+3.0%)
Mar 2021
-
-41.08%(-4.2%)
Dec 2020
-42.47%(+6.4%)
-42.89%(+7.1%)
Sep 2020
-
-40.04%(+9.5%)
Jun 2020
-
-36.57%(-12.9%)
Mar 2020
-
-41.99%(-4.5%)
Dec 2019
-39.93%(-33.7%)
-43.98%(-21.9%)
Sep 2019
-
-56.32%(-25.4%)
Jun 2019
-
-75.48%(-7.6%)
Mar 2019
-
-81.73%(+7.1%)
Dec 2018
-60.22%(-11.2%)
-76.30%(-7.6%)
Sep 2018
-
-82.59%(+11.4%)
Jun 2018
-
-74.17%(+9.5%)
Mar 2018
-
-67.71%(-1.6%)
Dec 2017
-67.80%(-10.3%)
-68.78%(+7.9%)
Sep 2017
-
-63.76%(-0.8%)
Jun 2017
-
-64.26%(0.0%)
Mar 2017
-
-64.26%(+1.8%)
Dec 2016
-75.58%(+17.0%)
-63.11%(-1.6%)
Sep 2016
-
-64.13%(-4.2%)
Jun 2016
-
-66.94%(+8.8%)
Mar 2016
-
-61.50%(-4.4%)
Dec 2015
-64.58%(+71.7%)
-64.36%(+23.3%)
Sep 2015
-
-52.20%(+20.3%)
Jun 2015
-
-43.40%(+23.8%)
Mar 2015
-
-35.05%(+16.6%)
Dec 2014
-37.62%
-30.07%(+11.2%)
Sep 2014
-
-27.03%(+9.7%)
Jun 2014
-
-24.63%(-0.1%)
DateAnnualQuarterly
Mar 2014
-
-24.65%(-3.3%)
Dec 2013
-26.65%(-19.5%)
-25.49%(-9.6%)
Sep 2013
-
-28.20%(-4.9%)
Jun 2013
-
-29.64%(-29.2%)
Mar 2013
-
-41.86%(-30.1%)
Dec 2012
-33.09%(-61.4%)
-59.92%(-38.4%)
Sep 2012
-
-97.22%(+1.2%)
Jun 2012
-
-96.03%(+16.2%)
Mar 2012
-
-82.67%(+10.5%)
Dec 2011
-85.82%(-218.5%)
-74.82%(-264.8%)
Sep 2011
-
45.40%(-24.9%)
Jun 2011
-
60.45%(-36.4%)
Mar 2011
-
94.98%(-34.9%)
Dec 2010
72.43%(-152.2%)
145.90%(-152.9%)
Sep 2010
-
-275.64%(+37.4%)
Jun 2010
-
-200.68%(+16.0%)
Mar 2010
-
-173.01%(+14.1%)
Dec 2009
-138.68%(+80.2%)
-151.63%(+22.1%)
Sep 2009
-
-124.19%(+15.0%)
Jun 2009
-
-108.03%(+16.0%)
Mar 2009
-
-93.14%(+19.8%)
Dec 2008
-76.97%(+23.6%)
-77.77%(+13.2%)
Sep 2008
-
-68.72%(+15.2%)
Jun 2008
-
-59.66%(+7.7%)
Mar 2008
-
-55.41%(+0.6%)
Dec 2007
-62.28%(-26.4%)
-55.08%(+1.3%)
Sep 2007
-
-54.37%(+0.6%)
Jun 2007
-
-54.03%(-25.7%)
Mar 2007
-
-72.76%(+1.1%)
Dec 2006
-84.67%(-13.1%)
-71.97%(-0.8%)
Sep 2006
-
-72.54%(-8.1%)
Jun 2006
-
-78.91%(-8.0%)
Mar 2006
-
-85.75%(+6.9%)
Dec 2005
-97.46%(+122.3%)
-80.22%(+8.1%)
Sep 2005
-
-74.18%(+20.4%)
Jun 2005
-
-61.60%(-10.5%)
Mar 2005
-
-68.79%(+27.0%)
Dec 2004
-43.85%(+562.4%)
-54.18%(-40.1%)
Sep 2004
-
-90.47%(-54.0%)
Jun 2004
-
-196.59%(-2239.2%)
Mar 2004
-
9.19%(+279.8%)
Dec 2003
-6.62%(-86.9%)
2.42%
Dec 2002
-50.63%(-501.2%)
-
Dec 2001
12.62%(-248.5%)
-
Dec 2000
-8.50%
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual return on equity?
  • What is the all time high annual ROE for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual ROE year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly ROE year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual return on equity?

The current annual ROE of ACAD is 38.89%

What is the all time high annual ROE for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual return on equity is 72.43%

What is ACADIA Pharmaceuticals Inc. annual ROE year-on-year change?

Over the past year, ACAD annual return on equity has changed by +53.62% (+364.02%)

What is ACADIA Pharmaceuticals Inc. quarterly return on equity?

The current quarterly ROE of ACAD is 32.53%

What is the all time high quarterly ROE for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly return on equity is 145.90%

What is ACADIA Pharmaceuticals Inc. quarterly ROE year-on-year change?

Over the past year, ACAD quarterly return on equity has changed by +25.49% (+362.07%)
On this page